QMS Medical Allied Services received in-principle approval from the National Stock Exchange of India (NSE) on June 03, 2026, to migrate its equity shares listing from the SME Platform (EMERGE) to the main board. This development follows the board's earlier approval of the Information Memorandum for this strategic migration during its meeting on May 30, 2026. The move aims to provide greater liquidity and visibility for the company's shares in the capital markets.

The company had previously reported its financial results for the year ended March 31, 2026, showing a 13% decline in consolidated net profit to ₹1,191.68 lakh despite an 11% rise in revenue from operations to ₹17,287.65 lakh. The board had recommended a final dividend of ₹0.50 per share, subject to shareholder approval.

Consolidated Financial Performance

Rising expenses impacted the consolidated bottom line during FY26, with total expenses increasing to ₹15,748.97 lakh from ₹13,906.78 lakh in the previous year. Profit before tax stood at ₹1,643.99 lakh compared to ₹1,866.21 lakh in FY25. Profit attributable to owners of the company declined to ₹1,013.21 lakh from ₹1,209.23 lakh, while non-controlling interest accounted for ₹178.47 lakh. Basic and diluted earnings per share (EPS) fell to ₹5.40 from ₹6.65.

Standalone Financial Performance

On a standalone basis, net profit fell to ₹669.08 lakh from ₹1,042.06 lakh in FY25. Revenue from operations grew to ₹15,229.73 lakh from ₹14,486.74 lakh, while total expenses rose to ₹14,319.98 lakh from ₹13,090.15 lakh. Profit before tax was ₹945.22 lakh, down from ₹1,442.17 lakh in the prior year.

Corporate Actions and Auditor Details

The board recommended a final dividend of 5%, or ₹0.50 per equity share, for FY26, pending shareholder approval. It also approved the re-appointment of M/s. Khushbu Parekh & Co., Chartered Accountants, as internal auditors for FY 2026-27. H.H. Dedhia And Associates, the statutory auditors, issued an unmodified opinion on the financial statements. The consolidated results include subsidiary Saarthi Healthcare Private Limited, which reported total assets of ₹4,328.44 lakh as of March 31, 2026.

QMS Medical Allied Services Limited has announced the scheduling of its Q4 & FY26 Earnings Conference Call, pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The call will cover the company's financial results for the half year ended March 31, 2026. The intimation was filed with the National Stock Exchange of India Ltd. and signed by Company Secretary and Compliance Officer Toral Bhadra on May 30, 2026.

Earnings Call Details

The following key details have been disclosed for the upcoming earnings conference call:

Management Representatives

The earnings call will feature participation from senior company leadership:

• Mr. Mahesh Makhija — Chairman & Managing Director
• Mr. Mohit Tamhankar — Director Compliance

Investor Relations Contact

For further information regarding the earnings call, investors and analysts may reach out to the designated investor relations contacts:

Dial-in details for the conference call are available on the company's official website at www.qmsmas.com . The filing was submitted from Mumbai and is in compliance with applicable SEBI disclosure requirements.